Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.

@article{Forauer2014CancerfreeSA,
  title={Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.},
  author={A. Forauer and B. Dewey and J. Seigne},
  journal={Urologic oncology},
  year={2014},
  volume={32 6},
  pages={
          869-76
        }
}
  • A. Forauer, B. Dewey, J. Seigne
  • Published 2014
  • Medicine
  • Urologic oncology
  • OBJECTIVES There are numerous reports describing the use of radiofrequency ablation (RFA) to treat renal cell carcinoma. Many series, however, describe heterogeneous populations, lack histologic descriptions, use various RFA systems, and indicate tumor destruction by different ablation end points. This study examined the outcomes of computed tomography-guided, impedance-based RFA of biopsy-proven renal cell carcinoma clinically staged as T1a with a minimum of 1 year of postablation follow-up… CONTINUE READING
    10 Citations
    Update on ablative therapies of renal tumors
    • 10
    Evaluating the microRNA-target gene regulatory network in renal cell carcinomas, identification for potential biomarkers and critical pathways.
    • J. Li, J. Huang, +4 authors C. Sheng
    • Biology, Medicine
    • International journal of clinical and experimental medicine
    • 2015
    • 3
    • PDF

    References

    SHOWING 1-10 OF 36 REFERENCES
    Imaging-guided radiofrequency ablation of solid renal tumors.
    • 260
    Management of Renal Tumors by Image-Guided Radiofrequency Ablation: Experience in 105 Tumors
    • 138